BIOID Trademark
Trademark Overview
On Wednesday, February 7, 2024, a trademark application was filed for BIOID with the United States Patent and Trademark Office. The USPTO has given the BIOID trademark a serial number of 98396247. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, December 18, 2024. This trademark is owned by Biomedical Health LLC. The BIOID trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical diagnostic testing, monitoring and reporting services; Providing medical information in the field of hormone replacement therapy, nutraceutical therapy and nutrient IV therapy; Providing medical information, namely, customized printed report featuring patient's biomarkers and diagnostic information; Providing medical record analysis and assessment of medical profiles and diagnostic testing that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of diagnostic tests, symptoms and concerns; Providing medical information, namely, a customized printed report with patient's medical profile, medical record analysis, and results of patient's diagnostic tests which is designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms
General Information
| Serial Number | 98396247 |
| Word Mark | BIOID |
| Filing Date | Wednesday, February 7, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, December 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | BIO ID |
| Goods and Services | Medical diagnostic testing, monitoring and reporting services; Providing medical information in the field of hormone replacement therapy, nutraceutical therapy and nutrient IV therapy; Providing medical information, namely, customized printed report featuring patient's biomarkers and diagnostic information; Providing medical record analysis and assessment of medical profiles and diagnostic testing that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of diagnostic tests, symptoms and concerns; Providing medical information, namely, a customized printed report with patient's medical profile, medical record analysis, and results of patient's diagnostic tests which is designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 7, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Tuesday, April 8, 2014 |
| First Use In Commerce Date | Tuesday, April 8, 2014 |
Trademark Owner History
| Party Name | Biomedical Health LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Delray Beach, FL 33483 |
Trademark Events
| Event Date | Event Description |
| Wednesday, February 7, 2024 | NEW APPLICATION ENTERED |
| Thursday, June 6, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 19, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, September 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, September 19, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 18, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 18, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, August 31, 2024 | ASSIGNED TO EXAMINER |
